Sleep Quality and Architecture
Studies examine sleep efficiency, awakenings, and sleep stages. Some reported changes in selected measures; others found limited or uncertain benefit.
DSIP (Emideltide)
Explore emerging sleep research and individualized guidance for your sleep-health concerns.
Book Your Appointment
What Is DSIP?
Delta Sleep-Inducing Peptide (DSIP), also called emideltide, contains nine amino acids. Researchers study its links to sleep and signals between nerves and hormones. Its exact role in humans remains unclear.
An emerging research topic: DSIP is not an FDA-approved sleep medication. Small, largely older human studies have produced mixed findings, leaving clinical effectiveness and safety uncertain.
Why Researchers Study DSIP
Early studies explored when sleep begins, how long it lasts, and how often it breaks. These findings sparked interest. However, they have not established a reliable treatment effect.
Circadian and Sleep-Wake Processes
Researchers explore links to daily rhythms and falling asleep. However, studies have not shown that DSIP reliably resets a person’s sleep cycle.
Stress and Neuroendocrine Signaling
Lab research examines links between nerves, hormones, and stress responses. It is too early to draw treatment conclusions.
Other Historical Research
Researchers have also explored DSIP in narcolepsy and opioid withdrawal. This work does not establish that it treats either condition.
Putting Sleep Research in Perspective
Better sleep involves more than a single signal or compound. Discuss DSIP research as part of a broader review of your symptoms and health.
What Was Measured?
A change in one sleep measure may not mean you feel or function better during the day.
How Strong Is the Study?
Small samples, older methods, and mixed findings limit confidence. Researchers need larger, modern controlled trials.
What Is Still Unknown?
Research has not established the best dose, route, duration, interactions, or long-term safety.
Start With Your Sleep Concerns
Persistent insomnia or daytime sleepiness deserves a clinical assessment. Your visit can explore what is disrupting sleep and which established options fit your needs.
Review the Full Picture
Discuss sleep schedule, snoring, medications, stress, mood, and relevant medical or hormonal concerns.
Find a Practical Next Step
Your provider may recommend testing, sleep-specialist evaluation, or established care rather than an investigational peptide.
Safety: What We Know and What We Do Not
Limited human evidence leaves many side effects unknown. A short list of reported symptoms is not a complete safety assessment.
Immune and Product Concerns
FDA has identified possible immune-reaction risks and concerns about peptide impurities and ingredient quality. Safety information for proposed routes is also limited.
Interactions and Individual Health
Researchers have not adequately studied effects with sedatives and other medicines. Pregnancy, breastfeeding, and serious nerve or mental health conditions require particular caution and professional guidance.
Injection routes add risks such as irritation, contamination, and infection. Research descriptions are not instructions for use. Do not experiment on yourself with unverified products.
Questions to Bring to Your Consultation
A useful discussion connects the research to your actual sleep experience.
Your Sleep Pattern
When did the problem begin? Is the difficulty falling asleep, staying asleep, or feeling rested?
Your Health and Medications
What conditions, prescriptions, supplements, or schedule changes might contribute?
Your Care Options
What tests or established treatments might help? How will we track progress?
Research Review & Pharmacy Standards
Emideltide-related substances have undergone FDA compounding advisory review. That process is separate from drug approval and does not itself establish access to a product.
Understand the Status
A substance registration, nomination, or committee discussion does not mean FDA has approved DSIP or added it to a final compounding list.
Avoid Assumptions About Availability
Any potential offering must meet current federal and state requirements. This page does not promise a prescription, supply, or future availability date.
Compounded medicines are not FDA-approved. A licensed pharmacy or independent quality testing does not replace evidence of clinical safety or establish permission to compound a particular substance.
Frequently Asked Questions
Are DSIP and emideltide the same?
Yes. Emideltide is another name for delta sleep-inducing peptide, a nine-amino-acid peptide.
Is DSIP FDA-approved?
No. FDA compounding review and substance registration do not mean approval of a medicine.
Can DSIP treat insomnia?
Small historical studies investigated insomnia, but findings are mixed and insufficient to establish DSIP as a standard treatment.
Does it improve deep sleep?
Available evidence does not establish a reliable increase in deep sleep or a predictable change in sleep stages.
Is it like a conventional sleeping pill?
Researchers do not fully understand how DSIP works or its effects. Do not assume it acts like, or is safer than, established sleep medicines.
Can it be combined with sleep medications or other peptides?
Research has not established interactions or combination safety. Bring a full medicine and supplement list to your clinician. Do not add an investigational product on your own.
What can Alpha Hormones help me with?
Our team can review sleep concerns, medical history, and research questions, then discuss appropriate evaluation and available care options. A consultation does not guarantee DSIP access.
Personalized Guidance for Better Sleep
Our Pasadena team takes time to understand your concerns and explain your options.
Bring your questions about DSIP, sleep research, and your health goals. Together, we can identify an appropriate next step.
